GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Taiwan Bio Therapeutics 6892.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

25.75

+5.53%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 50.4m

FY2020FY2025

Net income

−TWD 381.6m

FY2020FY2025

Free cash flow

−TWD 244.4m

FY2020FY2025

Shareholders' equity

TWD 729.6m

FY2020FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020
RevenueTWD 50.4mTWD 105.1mTWD 85.5mTWD 44.7mTWD 27.2m—
Research and developmentTWD 342.0mTWD 345.6mTWD 244.6mTWD 181.6mTWD 92.6mTWD 31.4m
Operating income−TWD 384.3m−TWD 351.4m−TWD 212.2m−TWD 182.6m−TWD 87.3m−TWD 34.9m
Net income−TWD 381.6m−TWD 351.8m−TWD 217.5m−TWD 188.6m−TWD 90.2m−TWD 35.0m
Diluted earnings per share-4.52-4.72-3.50-2.24-1.07-0.42

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020
Total assetsTWD 1.35bnTWD 1.47bnTWD 941.8mTWD 871.0mTWD 590.1mTWD 199.6m
Cash and short-term investments—TWD 677.7mTWD 248.1mTWD 245.9mTWD 59.7mTWD 36.5m
Total liabilitiesTWD 625.1mTWD 380.6mTWD 328.5mTWD 344.2mTWD 333.6mTWD 132.4m
Debt—TWD 316.1mTWD 268.6mTWD 286.6mTWD 291.3mTWD 3.7m
Shareholders' equityTWD 729.6mTWD 1.09bnTWD 613.3mTWD 526.8mTWD 256.5mTWD 67.2m
Shares outstanding84m75m62m84m84m84m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020
Cash from operations−TWD 212.3m−TWD 252.4m−TWD 166.5m−TWD 140.0m−TWD 59.2m−TWD 30.4m
Capital spending−TWD 32.1m−TWD 110.9m−TWD 119.2m−TWD 83.2m−TWD 174.7m−TWD 31.1m
Free cash flow−TWD 244.4m−TWD 363.3m−TWD 285.8m−TWD 223.2m−TWD 233.8m−TWD 61.5m

Latest quarters

By quarter end

Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023
RevenueTWD 13.6mTWD 11.4mTWD 65.6mTWD 11.7mTWD 12.1mTWD 15.6mTWD 61.9mTWD 11.1m
Operating income−TWD 107.0m−TWD 77.0m−TWD 87.0m−TWD 123.2m−TWD 78.5m−TWD 62.7m——
Net income−TWD 116.4m−TWD 76.0m−TWD 90.6m−TWD 123.2m−TWD 76.8m−TWD 61.2m−TWD 37.3m−TWD 53.2m
Diluted earnings per share-1.38-0.90-1.22-1.65-1.03-0.82-0.60-0.86
Cash from operations−TWD 48.0m−TWD 57.0m−TWD 88.0m−TWD 70.0m−TWD 66.0m−TWD 27.0m−TWD 23.0m−TWD 53.0m
Capital spending−TWD 11.0m−TWD 7.0m−TWD 7.0m−TWD 9.0m−TWD 47.0m−TWD 46.0m−TWD 82.0m−TWD 10.0m
Free cash flow−TWD 59.0m−TWD 64.0m−TWD 95.0m−TWD 79.0m−TWD 113.0m−TWD 73.0m−TWD 105.0m−TWD 63.0m
Total assetsTWD 1.29bnTWD 1.41bnTWD 1.47bnTWD 1.11bnTWD 1.21bnTWD 1.27bnTWD 941.8m—
Cash and short-term investmentsTWD 529.6mTWD 588.4mTWD 677.7mTWD 370.8mTWD 438.7mTWD 558.1mTWD 248.1m—
DebtTWD 30.8mTWD 61.3mTWD 61.0mTWD 37.0mTWD 18.4mTWD 18.3mTWD 18.1m—
Shareholders' equityTWD 898.8mTWD 1.02bnTWD 1.09bnTWD 774.4mTWD 886.0mTWD 957.2mTWD 613.3m—

Financial ratios

Data as of 27 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin-742.7%-329.8%-248.3%-408.1%-321.6%—
Net margin-756.8%-334.7%-254.5%-421.4%-332.1%—
Return on equity-52.3%-32.2%-35.5%-35.8%-35.2%-52.2%
Return on assets-28.2%-23.9%-23.1%-21.6%-15.3%-17.6%
Free cash flow yield-8.1%-7.2%-2.9%———
Revenue growth-52.0%23.0%91.0%64.8%——
Earnings growth8.5%61.7%15.4%109.0%157.4%—
Current ratio4.01x10.16x5.41x5.38x1.92x0.32x
Debt to equity—0.06x0.03x0.03x0.07x0.02x
Equity ratio53.9%74.1%65.1%60.5%43.5%33.7%
Interest coverage-52.85x-66.47x-39.98x-33.69x-30.57x-298.46x
R&D as a share of sales678.1%328.9%286.2%405.8%340.8%—
Buybacks as a share of market value-13.2%-20.0%————

Growth per year

Compound annual rate

3 years5 years10 years
Revenue4.1%——
Operating income28.1%61.6%—
Net income26.5%61.2%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-473.1%-395.6%——
Net margin-471.6%-398.8%——

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022
Price to earnings-6.3-8.7-9.7-14.2
Price to sales47.729.124.759.9

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.